[Inhibitory effects of tetraethylammonium on proliferation and voltage-gated potassium channels in human cervical carcinoma cell line SiHa]. 2006

Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
Medical Center of Tumor Biology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P. R. China.

OBJECTIVE Various potassium channels are known to be involved in proliferation of many malignant cell lines. This study was to explore the role of voltage-gated potassium channels in proliferation of human cervical carcinoma cells through observing the effects of tetraethylammonium (TEA) on proliferation and outward potassium currents in human cervical carcinoma cell line SiHa. METHODS SiHa cells were treated with TEA. The effect of TEA on proliferation of SiHa cells was assessed by MTT assay. Cell apoptosis and cell cycle were detected by flow cytometry with Hoechst 33258 staining. The outward potassium currents were recorded by patch clamp technique. RESULTS TEA inhibited the proliferation of SiHa cells in dose-and time-dependent manners, and induced cell apoptosis. The cell cycle was arrested at G0/G1 phase after treatment with TEA. Exposure of SiHa cells to 10 mmol/L TEA reduced the peak outward potassium currents significantly from (260+/-12) pA to (58+/-6) pA (P<0.01). CONCLUSIONS Voltage-gated potassium channels play an important role in regulating proliferation of cervical carcinoma SiHa cells. Blocking voltage-gated potassium channels could inhibit proliferation of SiHa cells.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019789 Tetraethylammonium A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90) Tetraethylammonium Chloride,Tetraethylammonium Ion,Tetraethylammonium Bromide,Tetraethylammonium Hydroxide,Tetraethylammonium Iodide,Bromide, Tetraethylammonium,Chloride, Tetraethylammonium,Hydroxide, Tetraethylammonium,Iodide, Tetraethylammonium,Ion, Tetraethylammonium
D024642 Potassium Channels, Voltage-Gated Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL. Voltage-Gated Potassium Channels,Kv Potassium Channels,Potassium Channel, Voltage-Gated,Voltage-Gated K+ Channels,Voltage-Gated Potassium Channel,K+ Channels, Voltage-Gated,Potassium Channel, Voltage Gated,Potassium Channels, Kv,Potassium Channels, Voltage Gated,Voltage Gated K+ Channels,Voltage Gated Potassium Channel,Voltage Gated Potassium Channels

Related Publications

Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
October 2004, Physiology (Bethesda, Md.),
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
May 1992, Neuron,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
July 2003, Brain research. Molecular brain research,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
March 2019, Cancers,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
August 1995, Biophysical journal,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
May 2014, Cellular and molecular neurobiology,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
February 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
January 2002, Sheng li ke xue jin zhan [Progress in physiology],
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
October 1994, Molecular pharmacology,
Xiao-Bing Han, and Fang Wang, and Wei-Xing Yao, and You-Qing Liu, and Gang Wang, and Ding Ma
July 2000, Lancet (London, England),
Copied contents to your clipboard!